Xylo Technologies Ltd.
MDGSNASDAQHealthcare
$2.36
+$0.22(+10.28%)
Market Cap$178860624
P/E Ratio—
52W High$7.17
52W Low$1.5396
Xylo Technologies Ltd. (MDGS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MDGS · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $91.72M | $91.86M | $10.12M | $0.53M | $0.27M |
| Cost of Revenue | $79.88M | $77.41M | $5.32M | $1.03M | $0.46M |
| Gross Profit | $11.84M | $14.45M | $4.80M | ($0.50M) | ($0.18M) |
| Gross Margin %(computed) | 12.91% | 15.73% | 47.45% | -94.73% | -66.67% |
| Operating Expenses | |||||
| R&D Expenses | $5.89M | $4.85M | $1.04M | $1.00M | $0.61M |
| G&A Expenses | $12.11M | $14.17M | $9.96M | $5.49M | $13.18M |
| Total Operating Expenses | $22.66M | $23.03M | $13.00M | $6.96M | $14.11M |
| Operating Income | ($23.32M) | ($13.78M) | ($8.20M) | ($7.38M) | ($14.42M) |
| Operating Margin %(computed) | -25.43% | -15.01% | -81.00% | — | — |
| Interest Income | $0.00M | $0.00M | $0.35M | $0.20M | $0.10M |
| Interest Expense | $1.53M | $2.31M | $0.35M | $0.00M | $0.00M |
| Income Before Tax | ($21.81M) | ($10.10M) | $4.15M | ($6.84M) | ($14.18M) |
| Income Tax Expense | ($0.07M) | $0.11M | $0.10M | $0.01M | ($0.00M) |
| Net Income | ($16.02M) | ($10.21M) | $4.05M | ($6.85M) | ($14.18M) |
| Net Margin %(computed) | -17.47% | -11.11% | 39.99% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-9.50 | $-6.28 | $0.13 | $-0.77 | $-2.72 |
| Wtd Avg Shares | 1.69M | 1.63M | 30.71M | 8.90M | 5.21M |
| EBITDA | ($27.27M) | ($11.99M) | ($22.23M) | ($7.89M) | ($14.46M) |
| EBITDA Margin %(computed) | -29.73% | -13.05% | -219.66% | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Xylo Technologies Ltd. data
About Xylo Technologies Ltd. (MDGS) Income Statement
Xylo Technologies Ltd. (MDGS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, MDGS reported revenue of $0.09B, gross profit of $0.01B (gross margin 12.91%), and net income of ($0.02B) — a net profit margin of -17.47%.
Frequently asked questions
MDGS · 4 questionsXylo Technologies Ltd. (MDGS) reported revenue of $0.09B for 2023, down 0.1% year-over-year.
MDGS revenueMDGS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09